MICROFLUIDIC BIOSENSORS 4- MINUTES RAPID TEST FOR COVID-19 ANTIBODY TEST (IgM/IgG)

Quick Details

TEST TIME	4 MINUTES
SPECIFICITY- 99.91%	99.91%
SENSITIVITY	91.3%
ACCURACY	98.85%
EU CE MARKINGS	REGISTERED
FDA EUA	UNDER PROCESS WITH NOTIFICATION GRANTED, PUBLIC SALES ALLOWED
TEST SAMPLE TYPE	FINGER TIP BLOOD
TEST TYPE	QUALITATIVE WITH INFECTION LEVELS INDICATED
READER ANALYZER	REQUIRED
ISO	13485
PACKING SPECIFICATION	25 TEST/ BOX
ACCESSORIES	LANCETS/ PIPETTES/ BUFFER
DIAGNOSTIC PARAMETERS	COVID-19 INFECTION- POSITIVE/NEGATIVE

OVERVIEW
Microfluidic Biosensors are capable of detecting and analyzing small sample volumes and providing automated sample preparation and reducing pressing times with the consumption of the lowest amounts of expensive reagents. These advantages promote the integration of Microfluidic Biosensors for Point-of Care Diagnostic Applications.

ADVANTAGES
THE FASTEST AND MOST RELIABLE RAPID TEST FOR THE DIAGNOSTIC DETECTION OF COVID-19 INFECTION.
Especially valuable for application environment which require immediate Test Results, such as Emmergency Operation, Air-freight passenger boarding.
Far more Sensitive to Colloidal Gold Rapid Test.
Sensitivity comparative with Elisa Antigen Test.
The Fastest Diagnostic Test in the world so far.